The Current State of OFEV® (nintedanib) in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype

Thursday, May 7, 2020 – On behalf of Boehringer lngelheim, Beth Keene cordially invites you to attend a presentation on: The Current State of OFEV® (nintedanib) in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype. Presented by: Paul Noble, MD, Cedars Sinai Medical Center Los Angeles, CA.

Space is limited, so please respond promptly. RSVP on or before Monday, May 4, 2020 by emailing to info@taggrp.com or by calling 1-877-925-9550.

View Flyer